Moderna has started human testing of corona vaccine on children below 12 years. The company said it aims to include 6,750 healthy children from the US and Canada. Earlier, they conducted a human test of the vaccine on 12 to 17-year-old children but have announced the results.

Human testing of the vaccine on children under 12 years of age: Researchers are looking at the response of the vaccine by starting human trials with young age children. Moderna said to do his research in 2 parts. The first part will include children between 2-12 years and they are going to have two doses. Each dose is 50 or 100 micrograms. While children under 2 years of age can be given 2 doses of 25, 50, or 100 micrograms. In the second phase of the trial, selected doses will be given to children. The researcher is going to monitor the participants one year after the second vaccination to check the effect of the vaccine. After which closing analysis will be done to find out which dose is best for each group.

Participants children, including innocents, will be under 12 years of age: Children are less likely to die of the disease or corona vaccine as compared to the adults, but their ability to spread the virus to others is more. Epidemiologists speak that vaccination of this section of the population is necessary. Moderna has announced the first patients to be dosed in the initial human trial of the 'next generation' of its vaccine this week.

The new vaccine, called MRN, is likely to be placed in refrigerators instead of freezers, to make its distribution and vaccination easier, especially in developing countries. Moderna's two-dose vaccine is one of the 3 vaccines approved for use in the US against corona. 2 other vaccines are Pfizer-Biotech and johnson & Johnson's single dose.

Also read:

Tokyo Olympics 2021 to follow all safety measures amid increasing corona cases

Shivraj government imposes night curfew, alert issued in Bhopal-Indore

Corona wreaks havoc in Bihar, health department releases guidelines for Holi